Bioventus Operating Cash Flow 2011-2026 | BVS

Annual Operating Cash Flow Bioventus

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
74.7 M	38.8 M	15.3 M	-13.5 M	23 M	71.8 M	40.7 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
74.7 M	-13.5 M	35.8 M

Quarterly Operating Cash Flow Bioventus

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.93 M	-	-	-19.3 M	-	-	-6 M	-	-	2.49 M	-	-18.8 M	-18.1 M	-21 M	-	9.87 M	-713 K	-18 M	-	46.4 M	25.5 M	17.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
46.4 M	-21 M	683 K

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	-478 M	$ 18.56	-	$ 196 M	China
Agilent Technologies A	1.48 B	$ 113.26	-	$ 34.4 B	USA
Co-Diagnostics CODX	-29.1 M	$ 1.63	-	$ 2.17 M	USA
Castle Biosciences CSTL	64.3 M	$ 18.88	-	$ 547 M	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Fulgent Genetics FLGT	21.1 M	$ 16.19	-	$ 490 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Interpace Biosciences IDXG	5.83 M	$ 1.8	-5.26 %	$ 7.96 M	USA
CareDx, Inc CDNA	42 M	$ 20.49	-	$ 1.09 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Lantheus Holdings LNTH	390 M	$ 96.67	-	$ 6.52 B	USA
Medpace Holdings MEDP	713 M	$ 419.17	-	$ 12.1 B	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Mettler-Toledo International MTD	956 M	$ 1 041.91	-	$ 21.5 B	Schweiz
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Myriad Genetics MYGN	1.8 M	$ 3.62	-	$ 335 M	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
NeoGenomics NEO	5.23 M	$ 8.36	-	$ 1.07 B	USA
National Research Corporation NRC	26.4 M	$ 18.93	-	$ 424 M	USA
Natera NTRA	-432 M	$ 196.91	-	$ 19.4 B	USA
Charles River Laboratories International CRL	738 M	$ 159.12	-	$ 7.89 B	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Guardant Health GH	-185 M	$ 98.66	-	$ 12.4 B	USA
Senseonics Holdings SENS	-59.1 M	$ 5.82	-	$ 243 M	USA
Personalis PSNL	-74.9 M	$ 6.71	-	$ 599 M	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
ICON Public Limited Company ICLR	1.29 B	$ 117.09	-	$ 9.66 B	Irlanda
Illumina ILMN	837 M	$ 143.24	-	$ 22.8 B	USA
Soleno Therapeutics SLNO	46.8 M	$ 52.99	-	$ 2.69 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	-3.84 M	$ 2.41	-	$ 5.54 M	USA
Thermo Fisher Scientific TMO	7.82 B	$ 448.21	-	$ 169 B	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 254.02	-	$ 21.1 B	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.58	-	$ 208 M	Irlanda
Celcuity CELC	-153 M	$ 134.72	-	$ 6.3 B	USA
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Twist Bioscience Corporation TWST	-47.6 M	$ 52.95	-	$ 3.17 B	USA
Neogen Corporation NEOG	58.2 M	$ 8.43	-	$ 1.83 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 187.94	-	$ 20.9 B	USA